Lareida, Anna
Terziev, Robert
Grossenbacher, Bettina
Andratschke, Nicolaus
Roth, Patrick
Rohrmann, Sabine
Stahel, Rolf
Guckenberger, Matthias
Le Rhun, Emilie
Weller, Michael
Wolpert, Fabian http://orcid.org/0000-0001-9024-8736
Article History
Received: 6 August 2019
Accepted: 23 September 2019
First Online: 30 September 2019
Compliance with ethical standards
:
: NA has received honoraria for advisory board participation from AstraZeneca and research grants from Brainlab AG.PR has received honoraria for advisory board participation and lectures from Bristol-Myers Squibb, Molecular Partners, MSD, Novartis and Roche. RS has received honoraria for advisory boards from Abbvie, Astra Zeneca, Boehringer Ingelheim, MSD, Pfizer, Roche and Takeda. Honoraria as a speaker were received from Astra Zeneca, Boehringer Ingelheim, MSD and Roche. DMC activity for Roche and Takeda was declared as well as financial support for clinical trials by AstraZeneca, BMS, Boehringer Ingelheim, Genentech, MSD, Roche, and Pfizer. MG has received research grants from AstraZeneca and Varian and and honoraria for lectures or advisory board participation or consulting from AstraZeneca. ELR has received research grants from Mundipharma and Amgen and honoraria for lectures or advisory board participation from Abbvie, Daiichi Sankyo, Mundipharma and Novartis. MW has received research grants from Abbvie, Bayer, Merck, Sharp & Dohme (MSD), Merck (EMD), Novocure, OGD2, Piqur, Roche and Adastra, and honoraria for lectures or advisory board participation or consulting from Abbvie, BMS, Celgene, Merck, Sharp & Dohme (MSD), Merck (EMD), Novocure, Orbus, Roche and Tocagen. FW has received travel support from Roche. AL no conflict of interest declared. RT no conflict of interest declared. BG no conflict of interest declared. RT no conflict of interest declared. SR no conflict of interest declared.